Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
MUSC Health Selects UpStream Healthcare as its Value-Based Partner for Medicare Patients
The Medical University of South Carolina (MUSC Health) and national value-based healthcare company, UpStream Healthcare, have […]
Optibrium Strengthens Global AI Drug Discovery Software Operations With Three Key Appointments
Optibrium, a leading developer of software and artificial intelligence (AI) solutions for drug discovery, today […]
Pfizer Completes Acquisition of Biohaven Pharmaceuticals
Pfizer Inc. (NYSE: PFE) announced today the completion of its acquisition of Biohaven Pharmaceutical Holding […]
Pheon Therapeutics Launches with $68 Million in Financing to Advance Novel Antibody-Drug Conjugates for Treatment of Solid Tumors
Pheon Therapeutics (Pheon), a leading Antibody-Drug Conjugate (ADC) specialist developing next generation ADCs for a wide […]
Flagship Biosciences Hires Tom Turi, Ph.D., as New Chief Scientific Officer
Flagship Biosciences, Inc., a leader in spatial biology and biomarker analytics services, announced the hiring […]
Cue Health Appoints Suzanne Stone as New Chief Commercial Officer
Cue Health Inc. (“Cue”) ( Nasdaq: HLTH), a healthcare technology company, today announced that it has appointed Suzanne […]
Nemaura and EVERSANA sign preliminary agreement for large-scale launch of Nemaura’s Diabetes Management Program in the U.S.
Nemaura Medical, Inc.(NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and […]
CraniUS Closes ~$20 Million Series A Funding Round
CraniUS LLC, an R&D company focused on building groundbreaking treatments for patients with chronic brain […]
Iain Mackay, Chief Financial Officer, to Retire From GSK, Julie Brown Appointed as Successor
GSK plc (LSE/NYSE: GSK) today announced that Iain Mackay, Chief Financial Officer (CFO), has decided […]
BioIVT Acquires Fidelis Research
BioIVT, a leading provider of biospecimens, research models and services for drug and diagnostic development, today […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more